Correlation Between Zivo Bioscience and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Zivo Bioscience and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zivo Bioscience and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zivo Bioscience and Nuvectis Pharma, you can compare the effects of market volatilities on Zivo Bioscience and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zivo Bioscience with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zivo Bioscience and Nuvectis Pharma.
Diversification Opportunities for Zivo Bioscience and Nuvectis Pharma
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Zivo and Nuvectis is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Zivo Bioscience and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Zivo Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zivo Bioscience are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Zivo Bioscience i.e., Zivo Bioscience and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Zivo Bioscience and Nuvectis Pharma
Given the investment horizon of 90 days Zivo Bioscience is expected to under-perform the Nuvectis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Zivo Bioscience is 1.04 times less risky than Nuvectis Pharma. The stock trades about -0.06 of its potential returns per unit of risk. The Nuvectis Pharma is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,185 in Nuvectis Pharma on November 2, 2024 and sell it today you would lose (511.00) from holding Nuvectis Pharma or give up 43.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 22.67% |
| Values | Daily Returns |
Zivo Bioscience vs. Nuvectis Pharma
Performance |
| Timeline |
| Zivo Bioscience |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Nuvectis Pharma |
Zivo Bioscience and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zivo Bioscience and Nuvectis Pharma
The main advantage of trading using opposite Zivo Bioscience and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zivo Bioscience position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Zivo Bioscience vs. RenovoRx | Zivo Bioscience vs. Pasithea Therapeutics Corp | Zivo Bioscience vs. Quoin Pharmaceuticals Ltd | Zivo Bioscience vs. Erasca Inc |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |